Nuzenio

Marketbeat Crispr Therapeutics

Marketbeat Crispr Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 10 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 05:48:57 GMTCRISPR Therapeutics (NASDAQ:CRSP) Rating Increased to Hold at Wall Street Zen - MarketBeat
Fri, 07 Aug 2026 11:30:16 GMTHC Wainwright Has Positive Forecast for CRSP FY2026 Earnings - MarketBeat
Fri, 07 Aug 2026 08:22:56 GMTCalifornia State Teachers Retirement System Increases Stock Position in CRISPR Therapeutics AG $CRSP - MarketBeat
Fri, 07 Aug 2026 08:20:29 GMTBrave Asset Management Inc. Cuts Stake in CRISPR Therapeutics AG $CRSP - MarketBeat
Fri, 07 Aug 2026 08:20:28 GMTDimensional Fund Advisors LP Sells 412,889 Shares of CRISPR Therapeutics AG $CRSP - MarketBeat
Thu, 06 Aug 2026 14:36:31 GMTEquities Analysts Offer Predictions for CRSP Q3 Earnings - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Marketbeat Crispr Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.